Puxin Bio
谱新生物
Puxin Bio
Biotech/Healthcare
Jiangsu Prosgen Biopharma Co., Ltd. is a cell and gene therapy CDMO with core technologies for commercial-scale production.
Latest round: Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.